Recent Company News

• 07:31 AM ET Sep 26, 2025
  

  Concord Medical Services Holding reports H1 EPS ($0.21) vs year-ago ($1.31) ($6.57, 0.00)

• 07:30 AM ET Sep 26, 2025
  

  Concord Medical Reports Financial Results for the First Half of 2025

• 06:00 PM ET Jul 14, 2025
  

  StreetAccount Summary - After-hours trading update

• 04:06 PM ET Jul 14, 2025
  

  Concord Healthcare announces completion first proton therapy for choroidal malignant melanoma in China ($5.22, 0.00)

• 05:02 PM ET May 29, 2025
  

  Concord Medical Services Holding's LLM in the vertical field of proton therapy was officially released and deployed in Guangzhou Concord Cancer Hospital - 6-K ($7.32, 0.00)

• 04:07 PM ET May 29, 2025
  

  Concord Medical Services Holding enters into best effort placing agreement to price 18.6M H shares at HK$5.38 with Guotai Junan Securities - 6-K ($7.32, 0.00)

• 04:07 PM ET Apr 25, 2025
  

  Concord Medical Services files 20-F; reports FY24 EPS (CNY2.35) vs year-ago (CNY2.27) - 20-F ($5.32, 0.00)

• 04:22 PM ET Apr 11, 2025
  

  Concord Medical Services Holding appoints Wei Jiang as CFO, effective 11-Apr - 6-K ($4.02, 0.00)

• 07:35 AM ET Dec 09, 2024
  

  Concord Medical Services Holding announces China has granted approval to the application for the registration certificate for medical device for the proton therapy equipment ($4.75, 0.00)

• 07:06 AM ET Sep 27, 2024
  

  Concord Medical Services Holding reports H1 EPS (CNY1.31) vs year-ago CNY0.69 ($6.50, 0.00)